Coston McIsaac & Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.87M | Buy |
55,879
+307
| +0.6% | +$26.8K | 1.26% | 27 |
|
|
2025
Q1 | $4.99M | Buy |
55,572
+525
| +1% | +$47.2K | 1.46% | 24 |
|
|
2024
Q4 | $4.4M | Sell |
55,047
-1,123
| -2% | -$89.7K | 1.3% | 26 |
|
|
2024
Q3 | $5.06K | Buy |
56,170
+1,580
| +3% | +$142 | 1.43% | 29 |
|
|
2024
Q2 | $4.3M | Buy |
54,590
+1,204
| +2% | +$94.8K | 1.35% | 29 |
|
|
2024
Q1 | $4.65M | Buy |
53,386
+1,697
| +3% | +$148K | 1.49% | 27 |
|
|
2023
Q4 | $4.26M | Buy |
51,689
+2,938
| +6% | +$242K | 1.48% | 27 |
|
|
2023
Q3 | $3.82M | Buy |
48,751
+4,471
| +10% | +$350K | 1.45% | 28 |
|
|
2023
Q2 | $3.9M | Buy |
44,280
+2,094
| +5% | +$184K | 1.34% | 30 |
|
|
2023
Q1 | $3.4M | Buy |
42,186
+6,882
| +19% | +$555K | 1.27% | 33 |
|
|
2022
Q4 | $2.74K | Sell |
35,304
-295
| -0.8% | -$23 | 1.07% | 35 |
|
|
2022
Q3 | $2.87M | Buy |
35,599
+5,652
| +19% | +$456K | 1.31% | 31 |
|
|
2022
Q2 | $2.69M | Buy |
+29,947
| New | +$2.69M | 1.62% | 31 |
|